After an infection, experts give advice on how to use eye creams correctly.

Published Date: 08 Mar 2023

Following a major outbreak involving the use of tear drops in 13 US states, experts are offering advice on how to protect dry eyes.

Read Full News

Latest News

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Eye Specialists Flag Concerns About Pricey Lenses in Cataract Surgery

Multifocal lenses are not for everyone, experts say

Anti-VEGF Agent Collects Big Win in Trial of Diabetic Retinopathy

More than 60% of tarcocimab-treated patients had reduced severity

New Agents for AMD Preserve Vision, Dramatically Reduce Treatment Burden

Bispecific antibody fares well against faricimab, two gene therapies extend treatment intervals

Consider This Before Cataract Surgery; Grant Rule: What's Next? CDC Nominee Grilled

MedPage Today reporters offer further insights into recently covered topics

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Multifocal lenses are not for everyone, experts say

More than 60% of tarcocimab-treated patients had reduced severity

Bispecific antibody fares well against faricimab, two gene therapies extend treatment intervals

MedPage Today reporters offer further insights into recently covered topics

News All Time

Massage Matches Clinic Probing for Infant Tear Duct Blockage

Gently massaging the tear sacs of infants with blocked tear ducts may be as effective as clinic-based probing for clearing tearing and discharge, a noninferiority trial finds.

Can Dexamethasone Drops Prevent Retinal Disease in Preemies?

Dexamethasone eye drops administered in premature infants with early-stage retinal disease appear to reduce the odds of progression to treatment-requiring disease.

Urinary Drug Tadalafil Linked to Glaucoma Risk

Men taking tadalafil for lower urinary tract symptoms face a 22% higher risk of developing glaucoma than those who do not take the drug, a new study finds.

Study Links Uveitis to Higher Risk for Psychiatric Illness

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

Nonvalved Drainage Device Benefits Kids With Glaucoma

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

What Is Causing Progressive Vision Problems in a 32-Year-Old Woman?

A glaucoma diagnosis at a young age should prompt timely genetic testing

Woman Develops Chorioretinal Anastomosis at Site of Photocoagulation Scar

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

What Caused Visual Disturbance in Kidney Transplant Patient?

Genetic testing identified PAX2 gene variant

Floaters Affect Vision of Kidney Transplant Patient

UL97- and UL54-resistant CMV retinitis treated with multivirus-specific T-cell therapy

Massage Gun Eye Injury: Retinal Tears, Detachment

'Hesitant historian' did not initially disclose that he used the product on his eyes

AI Smart Glasses Show Promise, Limitations as Aid for Patients With Low Vision

Good accuracy for recognizing common objects, mixed results by object size, colors, text, money

Loss of Payment Assistance for AMD Drugs Strains Patients and Ophthalmologists

— Pervasive "unsustainable" clinical practices amid cat-and-mouse game with funding availability

Recommended News For You

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Microplastics can cause malignant changes in lung cells

Smartphone App Detects Eye Cancers From Photos

A single bout of exercise gives results that could help cancer patients

Children with rare gliomas have new hope thanks to clinical trial results.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

Cancer death rates higher for children in neighborhoods with persistent poverty, study finds

Recommended Articles For You

Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology 

Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results 

Risk Assessment of Bone-Marrow Reserve Under Repeated Physiological Demands 

Uncovering the Hidden Symptoms of Parathyroid Cancer in Women 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New therapeutic strategies raised to prevent and resist metastasis in lymph nodes of breast cancer

2.

Gatekeeping May Reduce Pediatric Cancer Trial Participation

3.

Research team uncovers the underpinnings of head and neck cancers

4.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

5.

Resection for Early Liver Cancer Tied to Improved Survival.

1.

The Latest Research on Chronic Granulomatous Disease and Promising New Treatments 

2.

Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide

3.

The Unseen Danger of Anal Cancer: How to Protect Yourself

4.

Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells

5.

Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Navigating the Complexities of Ph Negative ALL - Part VIII

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

5.

Navigating the Complexities of Ph Negative ALL - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot